Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 public companies in the "Holding & other investment offices" industry, but how does it contrast to its rivals? We will compare Summit Healthcare Acquisition to similar companies based on the strength of its institutional ownership, profitability, analyst recommendations, valuation, earnings, dividends and risk.
Profitability
This table compares Summit Healthcare Acquisition and its rivals' net margins, return on equity and return on assets.
Get Summit Healthcare Acquisition alerts:Net Margins | Return on Equity | Return on Assets | |
Summit Healthcare Acquisition | N/A | 46.53% | 8.78% |
Summit Healthcare Acquisition Competitors | 11.67% | -68.35% | 2.51% |
Valuation & Earnings
This table compares Summit Healthcare Acquisition and its rivals revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Summit Healthcare Acquisition | N/A | -$550,000.00 | 12.51 |
Summit Healthcare Acquisition Competitors | $1.72 billion | $88.36 million | 25.15 |
Insider & Institutional Ownership
64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Summit Healthcare Acquisition and its rivals, as provided by MarketBeat.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Summit Healthcare Acquisition | 0 | 0 | 0 | 0 | N/A |
Summit Healthcare Acquisition Competitors | 113 | 591 | 885 | 18 | 2.50 |
As a group, "Holding & other investment offices" companies have a potential upside of 65.47%. Given Summit Healthcare Acquisition's rivals higher possible upside, analysts clearly believe Summit Healthcare Acquisition has less favorable growth aspects than its rivals.
Risk & Volatility
Summit Healthcare Acquisition has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's rivals have a beta of 0.05, suggesting that their average share price is 95% less volatile than the S&P 500.
Summary
Summit Healthcare Acquisition rivals beat Summit Healthcare Acquisition on 8 of the 10 factors compared.
About Summit Healthcare Acquisition
(Get Rating)
Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.
Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.